bpc-157 safety human use Peptide BPC-157 benefits, dosage, and side
Description
[PubMed] [Google Scholar] Kunji E
Anti-parietal cell antibodies support the diagnosis when combined with clinical presentation, though they are less specific
Convenient & Reliable Designed for multiple doses
In September 2023, the FDA classified BPC-157 as a Category 2 bulk substance, prohibiting its inclusion in compounded medications
